Insight journal - Company

Roche / Genentech: Partnering activity 2005-2013

Posted on 07 May 2013

Tags: , , ,

Roche announced over 375 partnering / licensing deals since 2005, with over 24 deals in 2012 alone, whilst Genentech announced over 98 partnering / licensing deals since 2005, with over 12 deals in 2012.

Analysis of the partnering deals shows a strong emphasis on partnerships in infectives, oncology, cardiovascular and psychiatry diseases.

Abstracted from: Partnering Deals and Alliances with Roche. Partnering Deals and Alliances with Genentech

The number of partnering, collaborative R&D and licensing deals announced varied year on year with a slight decline recently from the peak of 60 deals announced in 2009. This was probably due to the effects of the 2008 economic crisis making companies more selective in their deal making as budgets were squeezed.

The following figure shows the level of Roche partnering deal announcements since 2005.

Figure 1: Roche partnering deals 2005-2013

Roche deals frequency

Source: Current Agreements, 2013

The number of partnering, collaborative R&D and licensing deals announced by Genentech varied year on year with a slight decline recently from the peak of 20 deals announced in 2008. This was probably due to the effects of the 2008 economic crisis making companies more selective in their deal making as budgets were squeezed.

The following figure shows the level of Genentech partnering deal announcements since 2005.

Figure 2: Genentech partnering deals 2005-2013

Genentech deals frequency

Source: Current Agreements, 2013

Analysis of the partnering deals shows a strong emphasis on partnerships in infectives, oncology, cardiovascular and psychiatry diseases. This reflects the focus areas of Roche and Genentech strongly.

The following table provides an overview of the partnering deals announced by Roche and Genentech based on therapy area disclosed. Our reports provide more detailed insight into the precise therapeutic target of each deal. See: Partnering Deals and Alliances with Roche. Partnering Deals and Alliances with Genentech

Figure 3: Roche partnering deals by therapy area 2005-2013

Roche deals by  therapy

Source: Current Agreements, 2013

Figure 4: Genentech partnering deals by therapy area 2005-2013

Genentech deals by therapy

Source: Current Agreements, 2013

Further analysis of these deals shows that Roche and Genentech have a preference for collaborative R&D, development and licensing deals, similar to many other top pharmaceutical or big pharma companies. Such partnering deals provide the right for Roche/Genentech to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments.

The following tables provide an overview of the partnering deals announced by Roche/Genentech based on deal type disclosed.

Figure 5: Roche partnering deals by deal type 2005-2013

Roche deals by type

Source: Current Agreements, 2013

Figure 6: Genentech partnering deals by deal type 2005-2013

Genentech deals by type

Source: Current Agreements, 2013

When looking at stage of development at partnering deal signing, the most popular stage at signing for Roche and Genentech combined is discovery with 198 deal announcements, followed by preclinical stage with 65 deal announcements.

Both Roche and Genentech are also active in partnering at phase I, phase II and phase III stage deals. Such deals are of on-going importance to all top pharmaceutical companies as they seek to bolster their pipeline, fill gaps left as a result of drug candidates failing during clinical development, and ensure they have replacement products for when key drugs come off patent.

Marketed stage partnering also has a strong role to play with 40 deals announced.

The following figures provide an overview of the partnering deals announced by Roche and Genentech based on stage of development at signature.

Figure 7: Roche partnering by stage of development 2005-2013

Roche deals by stage of development

Source: Current Agreements, 2013

Figure 8: Genentech partnering by stage of development 2005-2013

Genentech deals by stage of development

Source: Current Agreements, 2013

Roche has signed over 375 partnering, collaborative R&D and licensing deals since 2005. The following provides a summary of the top deals by headline value.

Figure 9: Top Roche partnering deals by headline value 2005-2013

Roche top deals

Source: Current Agreements, 2013

Genentech has signed over 98 partnering, collaborative R&D and licensing deals since 2005. The following provides a summary of the top deals by headline value.

Figure 10: Top Genentech partnering deals by headline value 2005-2013

Genentech top deals

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Roche. Partnering Deals and Alliances with Genentech

Roche partnering at Current Agreements

View all partnering deals for Roche: 2013 | 20122011 | 2010 | 2009 | 2008 | 2007

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Deals and Alliances with Roche

Genentech partnering at Current Agreements

View all partnering deals for Genentech: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Deals and Alliances with Genentech

More

Summary profile data for Roche/Genentech

Partnering interests for Roche

Partnering interests for Genentech

M&A activity for Roche

 

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Roche

Report: Partnering Deals and Alliances with Genentech

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Roche / Genentech

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Roche company profile, recent partnering, M&A and financing news and articles

Read: more on Genentech company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email

Leave a Reply